近日，据"安徽药监局"公开披露行政处罚信息，因生产销售劣药款冬花，安徽汇仁堂中药饮片有限公司 被处以罚款61万元，被没收违法所得、没收非法财物的金额为1.442万元。行政处罚决定书文号是皖药 监药处罚〔2025〕2-83号。 2.没收违法所得13451.8元； 3.罚款610000元。 以上共计被罚没62.442万元。 天眼查信息显示，安徽汇仁堂中药饮片有限公司 (曾用名：安徽汇仁堂中药饮片股份有限公司) ，成立 于2011年，位于安徽省亳州市，是一家以从事医药制造业为主的企业。风险方面发现企业有涉诉关系1 条，开庭公告3条，立案信息3条。 公开处罚信息显示，安徽汇仁堂中药饮片有限公司于2024年1月生产款冬花（批号240101），经监督抽 检不符合规定，违反了《中华人民共和国药品管理法》第九十八条第一款、第三款，依据《中华人民共 和国药品管理法》第一百一十七条第一款，安徽省药品监督管理局决定： 1.没收款冬花（批号：240101）2.35kg； ...

Core Viewpoint - Traditional Chinese medicine offers various methods to help individuals quit smoking by addressing both the symptoms and underlying issues related to smoking addiction [1][6]. Group 1: Methods for Quitting Smoking - **Tea Replacement**: Drinking herbal teas such as green tea, mint, or licorice can help clear lung energy and reduce cravings. For those with weak stomachs, red tea can be used instead [1]. - **Herbal Decoction**: A combination of herbs like purple aster, winter flower, and loquat leaves can be used to alleviate symptoms such as cough and phlegm associated with smoking [2][3]. - **Herbal Patches**: Applying a patch made from herbs like cinnamon and clove can help reduce cravings and anxiety when used consistently over time [4]. - **Aromatherapy**: Carrying mugwort sticks and inhaling their aroma can create an aversion to the smell of cigarettes, aiding in the quitting process [5]. - **Acupuncture**: Stimulating specific ear points related to lung and bronchial health can help decrease the desire to smoke [5]. Group 2: Health Risks of Smoking - **Chemical Exposure**: Smoking releases over 7,000 chemicals, with nicotine acting as a highly addictive substance that affects the brain's reward system [6]. - **Cancer Risk**: Smokers are 23 times more likely to develop lung cancer compared to non-smokers, and the incidence of coronary heart disease increases by 2-4 times [6]. - **Secondhand Smoke Effects**: Children exposed to secondhand smoke face a 6-fold increase in respiratory infections and a 3-fold increase in asthma rates [6].

Core Viewpoint - The National Pharmacopoeia Commission has published 11 draft standards for the processing of traditional Chinese medicine (TCM) decoction pieces, addressing quality issues that have arisen this year due to frequent non-compliance in drug inspections [1][2]. Group 1: Draft Standards for TCM Decoction Pieces - The 11 draft standards cover various TCM decoction pieces including Banbianlian, Zisuye, Beishashen, Guanghuoxiang, Yimucao, Gaoliangjiang, Shudihuang, Shichangpu, Jingjie, Qicaotan, and Qicaoshan, specifying guidelines for processing, characteristics, and storage [2]. - For example, the processing standard for Banbianlian includes removing impurities, washing, cutting, drying, and sieving, while its characteristics and storage requirements are also detailed [2]. Group 2: Quality Inspection Reports - Multiple regions have reported non-compliance in TCM decoction pieces during drug quality inspections, with notable failures in Shanxi Province where 6 batches of decoction pieces were found non-compliant, involving well-known companies [3]. - In Jiangxi Province, 18 products were reported as non-compliant, including 11 batches of TCM materials and decoction pieces, with issues related to characteristics, identification, and microbial limits [4]. Group 3: Regulatory Actions and Expert Insights - Regulatory bodies are intensifying scrutiny on TCM decoction pieces, as evidenced by significant fines imposed on companies for producing substandard products, such as Anhui Baicui Jinfang Pharmaceutical Co., which faced penalties totaling 3.11 million yuan [4]. - Experts attribute the prevalence of substandard TCM decoction pieces to various factors, including the complexity of sourcing raw materials, lack of professional knowledge among suppliers, and the challenges of standardizing production practices [5][6].